APA (7th ed.) Citation

Goldschmidt, H., Mai, E. K., Dürig, J., Scheid, C., Weisel, K. C., Kunz, C., . . . Salwender, H. (2020). Response-adapted lenalidomide maintenance in newly diagnosed myeloma: Results from the phase III GMMG-MM5 trial. Leukemia, 34(7), . https://doi.org/10.1038/s41375-020-0724-1

Chicago Style (17th ed.) Citation

Goldschmidt, Hartmut, et al. "Response-adapted Lenalidomide Maintenance in Newly Diagnosed Myeloma: Results from the Phase III GMMG-MM5 Trial." Leukemia 34, no. 7 (2020). https://doi.org/10.1038/s41375-020-0724-1.

MLA (9th ed.) Citation

Goldschmidt, Hartmut, et al. "Response-adapted Lenalidomide Maintenance in Newly Diagnosed Myeloma: Results from the Phase III GMMG-MM5 Trial." Leukemia, vol. 34, no. 7, 2020, https://doi.org/10.1038/s41375-020-0724-1.